Glucagon Suppressed Proliferation Rate of Mammary Aplastic Carcinoma in Mice

Abstract
Glucagon injected into mice with mammary aplastic carcinoma retards the growth and prolongs the mean survival time of the animals. Glucagon stimulates the plaque-forming capacity and phagocytosis in tumor-bearing animals. Cyclophosphamide treatment abolishes the antitumor effect of glucagon, while the effect of the hormone is enhanced in Corynebacterium parvum [Propionibacterium acnes] pretreated animals. The tumor-retarding effects of glucagon apparently are mediated mainly by maintaining high B [bone marrow-derived cell]-type reactivity and phagocytosis.